Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2012-10, Vol.79 (16), p.1645-1652
Hauptverfasser: YEN YING LIM, ELLIS, Kathryn A, SZOEKE, Cassandra, VILLEMAGNE, Victor L, MARUFF, Paul, PIETRZAK, Robert H, AMES, David, DARBY, David, HARRINGTON, Karra, MARTINS, Ralph N, MASTERS, Colin L, ROWE, Christopher, SAVAGE, Greg
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1652
container_issue 16
container_start_page 1645
container_title Neurology
container_volume 79
creator YEN YING LIM
ELLIS, Kathryn A
SZOEKE, Cassandra
VILLEMAGNE, Victor L
MARUFF, Paul
PIETRZAK, Robert H
AMES, David
DARBY, David
HARRINGTON, Karra
MARTINS, Ralph N
MASTERS, Colin L
ROWE, Christopher
SAVAGE, Greg
description Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.
doi_str_mv 10.1212/WNL.0b013e31826e9ae6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1291630780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1291630780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-beccb49db1c7a84a131f8b38a290a6689fa779a6b4b375c6e5a1cdb89889a9f23</originalsourceid><addsrcrecordid>eNqNkc1LHEEQxRtJ0NXkPxDpSyCX0f6Y7Y-jiEmEJQoqyW2o7qnendDbvU73Bva_z4ibBDx5qkP93ntUPUJOOTvngouLH98X58wxLlFyIxRaQHVAZnwuVKOk-PmOzBgTppFGmyNyXMovxqaltofkSEimOVdyRrr7Oua0xJFiCOgrzYHCehfz0NOYoad1BYle3t1e0yWmXHcbpDlRn5dpqMNvpD36OCSkQ6IrhFhXO5pjP_lBv421fCDvA8SCH_fzhDx-uX64-tYsbr_eXF0uGi81q41D711re8e9BtMClzwYJw0Iy0ApYwNobUG51kk99wrnwH3vjDXGgg1CnpDPL76bMT9tsdRuPRSPMULCvC0dF3a6l2nD3oBOEUy2_BltX1A_5lJGDN1mHNYw7jrOuucWuqmF7nULk-xsn7B1a-z_if6-fQI-7QEoHmIYIfmh_OeUEXzeWvkHUsmRZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237503410</pqid></control><display><type>article</type><title>Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>YEN YING LIM ; ELLIS, Kathryn A ; SZOEKE, Cassandra ; VILLEMAGNE, Victor L ; MARUFF, Paul ; PIETRZAK, Robert H ; AMES, David ; DARBY, David ; HARRINGTON, Karra ; MARTINS, Ralph N ; MASTERS, Colin L ; ROWE, Christopher ; SAVAGE, Greg</creator><creatorcontrib>YEN YING LIM ; ELLIS, Kathryn A ; SZOEKE, Cassandra ; VILLEMAGNE, Victor L ; MARUFF, Paul ; PIETRZAK, Robert H ; AMES, David ; DARBY, David ; HARRINGTON, Karra ; MARTINS, Ralph N ; MASTERS, Colin L ; ROWE, Christopher ; SAVAGE, Greg ; AIBL Research Group ; For the AIBL Research Group</creatorcontrib><description>Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0b013e31826e9ae6</identifier><identifier>PMID: 23071163</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Aged, 80 and over ; Amyloid beta-Peptides - genetics ; Amyloid beta-Peptides - metabolism ; Amyloidosis - diagnostic imaging ; Amyloidosis - genetics ; Amyloidosis - metabolism ; Apolipoproteins E - genetics ; Biological and medical sciences ; Cognition Disorders - diagnostic imaging ; Cognition Disorders - genetics ; Cognition Disorders - psychology ; Data Interpretation, Statistical ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disease Progression ; Female ; Genotype ; Humans ; Linear Models ; Male ; Medical sciences ; Memory Disorders - genetics ; Memory Disorders - psychology ; Neurology ; Neuropsychological Tests ; Positron-Emission Tomography ; Prospective Studies ; Psychiatric Status Rating Scales</subject><ispartof>Neurology, 2012-10, Vol.79 (16), p.1645-1652</ispartof><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-beccb49db1c7a84a131f8b38a290a6689fa779a6b4b375c6e5a1cdb89889a9f23</citedby><cites>FETCH-LOGICAL-c370t-beccb49db1c7a84a131f8b38a290a6689fa779a6b4b375c6e5a1cdb89889a9f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26821549$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23071163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YEN YING LIM</creatorcontrib><creatorcontrib>ELLIS, Kathryn A</creatorcontrib><creatorcontrib>SZOEKE, Cassandra</creatorcontrib><creatorcontrib>VILLEMAGNE, Victor L</creatorcontrib><creatorcontrib>MARUFF, Paul</creatorcontrib><creatorcontrib>PIETRZAK, Robert H</creatorcontrib><creatorcontrib>AMES, David</creatorcontrib><creatorcontrib>DARBY, David</creatorcontrib><creatorcontrib>HARRINGTON, Karra</creatorcontrib><creatorcontrib>MARTINS, Ralph N</creatorcontrib><creatorcontrib>MASTERS, Colin L</creatorcontrib><creatorcontrib>ROWE, Christopher</creatorcontrib><creatorcontrib>SAVAGE, Greg</creatorcontrib><creatorcontrib>AIBL Research Group</creatorcontrib><creatorcontrib>For the AIBL Research Group</creatorcontrib><title>Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults</title><title>Neurology</title><addtitle>Neurology</addtitle><description>Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amyloid beta-Peptides - genetics</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloidosis - diagnostic imaging</subject><subject>Amyloidosis - genetics</subject><subject>Amyloidosis - metabolism</subject><subject>Apolipoproteins E - genetics</subject><subject>Biological and medical sciences</subject><subject>Cognition Disorders - diagnostic imaging</subject><subject>Cognition Disorders - genetics</subject><subject>Cognition Disorders - psychology</subject><subject>Data Interpretation, Statistical</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Genotype</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory Disorders - genetics</subject><subject>Memory Disorders - psychology</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Positron-Emission Tomography</subject><subject>Prospective Studies</subject><subject>Psychiatric Status Rating Scales</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1LHEEQxRtJ0NXkPxDpSyCX0f6Y7Y-jiEmEJQoqyW2o7qnendDbvU73Bva_z4ibBDx5qkP93ntUPUJOOTvngouLH98X58wxLlFyIxRaQHVAZnwuVKOk-PmOzBgTppFGmyNyXMovxqaltofkSEimOVdyRrr7Oua0xJFiCOgrzYHCehfz0NOYoad1BYle3t1e0yWmXHcbpDlRn5dpqMNvpD36OCSkQ6IrhFhXO5pjP_lBv421fCDvA8SCH_fzhDx-uX64-tYsbr_eXF0uGi81q41D711re8e9BtMClzwYJw0Iy0ApYwNobUG51kk99wrnwH3vjDXGgg1CnpDPL76bMT9tsdRuPRSPMULCvC0dF3a6l2nD3oBOEUy2_BltX1A_5lJGDN1mHNYw7jrOuucWuqmF7nULk-xsn7B1a-z_if6-fQI-7QEoHmIYIfmh_OeUEXzeWvkHUsmRZQ</recordid><startdate>20121016</startdate><enddate>20121016</enddate><creator>YEN YING LIM</creator><creator>ELLIS, Kathryn A</creator><creator>SZOEKE, Cassandra</creator><creator>VILLEMAGNE, Victor L</creator><creator>MARUFF, Paul</creator><creator>PIETRZAK, Robert H</creator><creator>AMES, David</creator><creator>DARBY, David</creator><creator>HARRINGTON, Karra</creator><creator>MARTINS, Ralph N</creator><creator>MASTERS, Colin L</creator><creator>ROWE, Christopher</creator><creator>SAVAGE, Greg</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20121016</creationdate><title>Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults</title><author>YEN YING LIM ; ELLIS, Kathryn A ; SZOEKE, Cassandra ; VILLEMAGNE, Victor L ; MARUFF, Paul ; PIETRZAK, Robert H ; AMES, David ; DARBY, David ; HARRINGTON, Karra ; MARTINS, Ralph N ; MASTERS, Colin L ; ROWE, Christopher ; SAVAGE, Greg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-beccb49db1c7a84a131f8b38a290a6689fa779a6b4b375c6e5a1cdb89889a9f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amyloid beta-Peptides - genetics</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloidosis - diagnostic imaging</topic><topic>Amyloidosis - genetics</topic><topic>Amyloidosis - metabolism</topic><topic>Apolipoproteins E - genetics</topic><topic>Biological and medical sciences</topic><topic>Cognition Disorders - diagnostic imaging</topic><topic>Cognition Disorders - genetics</topic><topic>Cognition Disorders - psychology</topic><topic>Data Interpretation, Statistical</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Genotype</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory Disorders - genetics</topic><topic>Memory Disorders - psychology</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Positron-Emission Tomography</topic><topic>Prospective Studies</topic><topic>Psychiatric Status Rating Scales</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>YEN YING LIM</creatorcontrib><creatorcontrib>ELLIS, Kathryn A</creatorcontrib><creatorcontrib>SZOEKE, Cassandra</creatorcontrib><creatorcontrib>VILLEMAGNE, Victor L</creatorcontrib><creatorcontrib>MARUFF, Paul</creatorcontrib><creatorcontrib>PIETRZAK, Robert H</creatorcontrib><creatorcontrib>AMES, David</creatorcontrib><creatorcontrib>DARBY, David</creatorcontrib><creatorcontrib>HARRINGTON, Karra</creatorcontrib><creatorcontrib>MARTINS, Ralph N</creatorcontrib><creatorcontrib>MASTERS, Colin L</creatorcontrib><creatorcontrib>ROWE, Christopher</creatorcontrib><creatorcontrib>SAVAGE, Greg</creatorcontrib><creatorcontrib>AIBL Research Group</creatorcontrib><creatorcontrib>For the AIBL Research Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YEN YING LIM</au><au>ELLIS, Kathryn A</au><au>SZOEKE, Cassandra</au><au>VILLEMAGNE, Victor L</au><au>MARUFF, Paul</au><au>PIETRZAK, Robert H</au><au>AMES, David</au><au>DARBY, David</au><au>HARRINGTON, Karra</au><au>MARTINS, Ralph N</au><au>MASTERS, Colin L</au><au>ROWE, Christopher</au><au>SAVAGE, Greg</au><aucorp>AIBL Research Group</aucorp><aucorp>For the AIBL Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2012-10-16</date><risdate>2012</risdate><volume>79</volume><issue>16</issue><spage>1645</spage><epage>1652</epage><pages>1645-1652</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>Although the APOE ε4 allele is associated with more rapid decline in memory in healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal changes in cognition is unclear. Healthy and cognitively normal older adults (n = 141; mean age 76 years) underwent PET neuroimaging for cerebral Aβ, APOE genotyping, and cognitive assessment as part of their baseline assessment in the Australian Imaging Biomarkers and Lifestyle study. Cognitive function was reassessed 18 months later. Linear mixed-model analyses adjusted for baseline cognitive function indicated that, relative to individuals with low cerebral Aβ, individuals with high cerebral Aβ showed significantly greater decline in working memory and verbal and visual episodic memory at 18 months. Compared with noncarriers, APOE ε4 carriers showed a greater decline in visual memory at the 18-month assessment. No interaction between APOE ε4 and cerebral Aβ load was observed for any measure of cognitive function. In this prospective study of healthy older adults, high cerebral Aβ load was associated with greater decline in episodic and working memory over 18 months. The APOE ε4 genotype was also associated with a decline in visual memory, although the effect was less than that observed for cerebral Aβ load.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>23071163</pmid><doi>10.1212/WNL.0b013e31826e9ae6</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2012-10, Vol.79 (16), p.1645-1652
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_1291630780
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Aged
Aged, 80 and over
Amyloid beta-Peptides - genetics
Amyloid beta-Peptides - metabolism
Amyloidosis - diagnostic imaging
Amyloidosis - genetics
Amyloidosis - metabolism
Apolipoproteins E - genetics
Biological and medical sciences
Cognition Disorders - diagnostic imaging
Cognition Disorders - genetics
Cognition Disorders - psychology
Data Interpretation, Statistical
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Disease Progression
Female
Genotype
Humans
Linear Models
Male
Medical sciences
Memory Disorders - genetics
Memory Disorders - psychology
Neurology
Neuropsychological Tests
Positron-Emission Tomography
Prospective Studies
Psychiatric Status Rating Scales
title Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stronger%20effect%20of%20amyloid%20load%20than%20APOE%20genotype%20on%20cognitive%20decline%20in%20healthy%20older%20adults&rft.jtitle=Neurology&rft.au=YEN%20YING%20LIM&rft.aucorp=AIBL%20Research%20Group&rft.date=2012-10-16&rft.volume=79&rft.issue=16&rft.spage=1645&rft.epage=1652&rft.pages=1645-1652&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/WNL.0b013e31826e9ae6&rft_dat=%3Cproquest_cross%3E1291630780%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237503410&rft_id=info:pmid/23071163&rfr_iscdi=true